Cargando…

Epigenetic Modifications in the Pathogenesis of Systemic Sclerosis

Systemic sclerosis is a rare chronic autoimmune disease, which mainly manifests as immune disorders, vascular damage, and progressive fibrosis. The etiology of SSc is complex and involves multiple factors. Both genetic and environmental factors are involved in its pathogenesis. As one of the molecul...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Jiangfan, Tang, Rui, Ding, Ke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942200/
https://www.ncbi.nlm.nih.gov/pubmed/35342304
http://dx.doi.org/10.2147/IJGM.S356877
_version_ 1784673255233159168
author Yu, Jiangfan
Tang, Rui
Ding, Ke
author_facet Yu, Jiangfan
Tang, Rui
Ding, Ke
author_sort Yu, Jiangfan
collection PubMed
description Systemic sclerosis is a rare chronic autoimmune disease, which mainly manifests as immune disorders, vascular damage, and progressive fibrosis. The etiology of SSc is complex and involves multiple factors. Both genetic and environmental factors are involved in its pathogenesis. As one of the molecular mechanisms of environmental factors, epigenetic regulation plays an important role in the occurrence and development of systemic sclerosis, which involves DNA methylation, histone modification and non-coding RNA regulation. This review summarizes research advances in epigenetics, including exosomes, lncRNA, and mentions possible biomarkers and therapeutic targets among them.
format Online
Article
Text
id pubmed-8942200
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-89422002022-03-24 Epigenetic Modifications in the Pathogenesis of Systemic Sclerosis Yu, Jiangfan Tang, Rui Ding, Ke Int J Gen Med Review Systemic sclerosis is a rare chronic autoimmune disease, which mainly manifests as immune disorders, vascular damage, and progressive fibrosis. The etiology of SSc is complex and involves multiple factors. Both genetic and environmental factors are involved in its pathogenesis. As one of the molecular mechanisms of environmental factors, epigenetic regulation plays an important role in the occurrence and development of systemic sclerosis, which involves DNA methylation, histone modification and non-coding RNA regulation. This review summarizes research advances in epigenetics, including exosomes, lncRNA, and mentions possible biomarkers and therapeutic targets among them. Dove 2022-03-19 /pmc/articles/PMC8942200/ /pubmed/35342304 http://dx.doi.org/10.2147/IJGM.S356877 Text en © 2022 Yu et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Review
Yu, Jiangfan
Tang, Rui
Ding, Ke
Epigenetic Modifications in the Pathogenesis of Systemic Sclerosis
title Epigenetic Modifications in the Pathogenesis of Systemic Sclerosis
title_full Epigenetic Modifications in the Pathogenesis of Systemic Sclerosis
title_fullStr Epigenetic Modifications in the Pathogenesis of Systemic Sclerosis
title_full_unstemmed Epigenetic Modifications in the Pathogenesis of Systemic Sclerosis
title_short Epigenetic Modifications in the Pathogenesis of Systemic Sclerosis
title_sort epigenetic modifications in the pathogenesis of systemic sclerosis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8942200/
https://www.ncbi.nlm.nih.gov/pubmed/35342304
http://dx.doi.org/10.2147/IJGM.S356877
work_keys_str_mv AT yujiangfan epigeneticmodificationsinthepathogenesisofsystemicsclerosis
AT tangrui epigeneticmodificationsinthepathogenesisofsystemicsclerosis
AT dingke epigeneticmodificationsinthepathogenesisofsystemicsclerosis